NSE filing, NSE: VMARCIND. Summary written from the filing by ALFA Finder's alert engine.
V-Marc India Ltd: key numbers
- Share price
- ₹320.05
- Market cap
- ₹4,690 Cr
- Revenue (annual)
- ₹1,797 Cr
- Net profit (annual)
- ₹100.0 Cr
- P/E (TTM)
- 46.9×Sector 42.1×
- Promoter holding
- 64.87%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from V-Marc India Ltd
All →V-Marc India Other Announcement
V-MARC India Limited has filed a compliance certificate for its Structured Digital Database as per PIT regulations for the quarter ended September 30, 2026.
V-Marc India Annual General Meeting
V-MARC India Limited held its 13th Annual General Meeting on September 25, 2026. Shareholders approved the company's migration from the NSE SME platform to the NSE Main Board.
V-Marc India Annual General Meeting
V-MARC India Limited will hold its 13th Annual General Meeting on September 25, 2026, to transact ordinary and special business, including director appointments and remuneration revisions.
V-Marc India Board Meeting Outcome
V-MARC India Limited's board approved increasing borrowing and asset charge limits to ₹1,000 Crore each. The board also recommended director appointments and remuneration revisions for shareholder approval.
- Value
- ₹1,000 Cr
V-Marc India SME to Main Board Migration
V-MARC India Limited's board approved migrating from the NSE SME platform to the NSE Main Board. The board also scheduled its 13th AGM for September 25, 2026.
V-Marc India Bags ₹100.7 Cr Order
V-Marc India Limited received three Letters of Intent from Purvanchal Vidyut Vitran Nigam Limited for supplying HT XLPE cables worth ₹100.74 Crore.
- Value
- ₹100.7 Cr
- Execution
- By January 2027
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.